Basics Repare Therapeutics Inc. IPO Date: May 2, 2022 Sector: Healthcare Industry: Biotech Market Cap: $58.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 3.21% Avg Daily Range (30 D): $0.04 | 3.09% Avg Daily Range (90 D): $0.04 | 2.97% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .27M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 281 Avg Trade Size (Sh.) (90 D): 247 Institutional Trades Total Inst.Trades: 59 Avg Inst. Trade: $1.63M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.49M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $2.61M Avg Closing Volume: 162.82K         News Jan 20, 2025 @ 3:30 PM CNL’S CNRI-H Program Continues Strong Growt... Source: N/A Jun 6, 2024 @ 1:59 PM Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets ... Source: Zacks Equity Research Feb 20, 2024 @ 3:00 PM Repare Therapeutics Inc. (RPTX) May Report Negativ... Source: Zacks Equity Research Feb 13, 2024 @ 9:45 AM Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Fur... Source: Zacks Equity Research Feb 1, 2024 @ 3:27 PM Biogen (BIIB) to Stop Selling Alzheimer's Disease ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.71 $-.81 Diluted EPS $-.71 $-.81 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -30.04M $ -34.41M Operating Income / Loss $ $ -31.19M $ -36.37M Cost of Revenue $ $ $ Net Cash Flow $ $ -.26M $ .72M PE Ratio